DUBLIN--(BUSINESS WIRE)--The "Nuclear Imaging Agents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030" report has been added to ResearchAndMarkets.com's offering.
Nuclear Imaging Agents Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Diagnostic Imaging therapeutic area.
The model discusses in detail the impact of COVID-19 on Nuclear Imaging Agents market for the year 2020 and beyond. Nuclear Imaging is a noninvasive medical technique which uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine and neurological diseases.
Nuclear Imaging Agent's have been classified into Positron Emission Tomography (PET) Systems and Single Photon Emission Computed Tomography (SPECT) Systems. The advanced version of these systems include PET/CT, PET/MRI, SPECT/CT and SPECT/MRI. These systems contain features of both PET and CT/MRI and SPECT and CT/MRI.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Currently marketed Nuclear Imaging Agents and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Nuclear Imaging Agents market revenue by segment and market outlooks from 2015-2030.
- Market level data on units, average selling prices and market values.
Global, Regional and Country level market specific insights:
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Nuclear Imaging Agents market.
- Competitive dynamics insights and trends provided for Nuclear Imaging Agents market.
Scope
- CMO executives who must have deep understanding of the Nuclear Imaging Agents marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
- Understand the impact of COVID-19 on Nuclear Imaging Agents market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving Nuclear Imaging Agents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Nuclear Imaging Agents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific Nuclear Imaging Agents market from 2015-2030.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned
- Cardinal Health Inc
- GE Healthcare
- Novartis AG
- Bracco Imaging SpA
- DuPont de Nemours Inc
For more information about this report visit https://www.researchandmarkets.com/r/crfr0k
